NASDAQ:UTHR

United Therapeutics Stock Forecast

etoro logo Buy UTHR
*Your capital is at risk
$536.59
-14.88 (-2.70%)
At Close: Jun 18, 2026
AI Analysis AI Analysis of UTHR AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add UTHR to Watchlist?
Some Reasons Why To Add UTHR:
  • High gross margin of 86.6%
  • +84.6% price growth over the last year
  • Strong operating margin of 45.3%
PDF

United Therapeutics Corporation stock downgraded from Hold/Accumulate to Sell Candidate after Thursday trading session
(Updated on Jun 18, 2026)

Sell candidate since Jun 18, 2026

The United Therapeutics Corporation stock price fell by -2.70% on the last day (Thursday, 18th Jun 2026) from $551.47 to $536.59. During the last trading day the stock fluctuated 4.25% from a day low at $532.62 to a day high of $555.23. The price has risen in 6 of the last 10 days but is still down by -2.03% for this period. Volume has increased on the last day by 940 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $687.02 million.

The stock is moving within a wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect United Therapeutics Corporation stock with a 90% probability to be traded between $511.02 and $588.57 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

UTHR Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The United Therapeutics Corporation stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $545.91 and $561.50. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, May 06, 2026, and so far it has fallen -10.08%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for United Therapeutics Corporation stock

United Therapeutics Corporation finds support from accumulated volume at $531.82 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $22.61 between high and low, or 4.25%. For the last week the stock has had daily average volatility of 2.54%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (UTHR) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect United Therapeutics Corporation to open at $541.48, and during the day (based on 14 day Average True Range), to move between $529.87 and $543.31, which gives a possible trading interval of +/-$13.44 (+/-2.54%) up or down from last closing price. If United Therapeutics Corporation takes out the full calculated possible swing range there will be an estimated 2.54% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $531.82 (0.89%) than the resistance at $564.81 (5.26%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is United Therapeutics Corporation stock A Buy?

United Therapeutics Corporation holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -3.164 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 22, 2026 - $541.48 ( 0.91%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

UTHR Performance

Trading levels for UTHR

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 564.09 5.12%
R2 555.45 3.52%
R1 550.12 2.52%
Price 536.59
S1 532.84 -0.698%
S2 527.51 -1.69%
S3 518.87 -3.30%

Accumulated Volume Support & Resistance Levels

Level Price
R3 592.98 10.51%
R2 588.36 9.65%
R1 564.81 5.26%
Price 536.59
S1 531.82 -0.89%
S2 524.28 -2.29%
S3 521.22 -2.86%

FAQ

What is the symbol for United Therapeutics Corporation Stock and on which exchange is it traded?
The symbol for United Therapeutics Corporation is UTHR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell United Therapeutics Corporation Stock?
United Therapeutics Corporation holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

How to buy United Therapeutics Corporation Stock?
United Therapeutics Corporation Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy United Therapeutics Corporation Stock.

What's the current price of United Therapeutics Corporation Stock?
As of the end of day on the Jun 18, 2026, the price of an United Therapeutics Corporation (UTHR) share was $536.59.

What is the 52-week high and low for United Therapeutics Corporation Stock?
The 52-week high for United Therapeutics Corporation Stock is $609.35 and the 52-week low is $272.18.

What is the market capitalization of United Therapeutics Corporation Stock?
As of the Jun 18, 2026, the market capitalization of United Therapeutics Corporation is 22.776B.

When is the next earnings date for United Therapeutics Corporation?
The upcoming earnings date for United Therapeutics Corporation is Jul 29, 2026.
Click to get the best stock tips daily for free!
ABOUT UNITED THERAPEUTICS CORPORATION
United Therapeutics
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Tyvaso, an inhaled formulation of prostacyclin a...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.76% Jun 12
DHI
$146.71
7.57% Jun 10
PHM
$118.49
7.15% Jun 10
EAT
$140.46
17.39% Jun 05
TPR
$140.47
2.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE